Adma Biologics | ADMA - Pre Utilidad Fiscal

Precio De Mercado
10.38
Cambio Diario
0.68 7.01%
Mensual
-34.47%
Anual
-50.36%
Q2 Expectativa
9.44




Pre Utilidad Fiscal Cambio Fecha
Adma Biologics USD 61.59M 14.07M 2025-12
Alnylam Pharmaceuticals USD 161.14M 77.83M 2025-12
BioCryst Pharmaceuticals USD 248.02M 235.89M 2025-12
Minerva Neurosciences USD 22.51M 30.74M 2024-09
Novavax USD 17.9M 220.94M 2025-12
Omeros USD -65.12M 21.27M 2024-06
Takeda JPY 133.86B 105.69B 2025-12